Q3 2023 Holdings
Filed 2023-11-13 | 30 holdings | $200.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $18.9M | 331,416 | 9.4% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $18.1M | 1,489,025 | 9.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $17.6M | 145,357 | 8.8% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $16.9M | 349,300 | 8.4% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $15.8M | 458,659 | 7.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $15.3M | 163,772 | 7.6% |
| Springworks Therapeutics Inc | COM | 85205L107 | $12.9M | 556,928 | 6.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $12.7M | 431,693 | 6.3% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $12.3M | 563,345 | 6.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $11.8M | 427,000 | 5.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $11.6M | 556,553 | 5.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $9.9M | 504,700 | 4.9% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $8.0M | 895,821 | 4.0% |
| Morphic Holding Inc | COM | 61775R105 | $7.5M | 325,356 | 3.7% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $7.3M | 870,870 | 3.6% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $2.4M | 961,251 | 1.2% |
| Calidi Biotherapeutics Inc | COM NEW | 320703101 | $415.6K | 125,000 | 0.2% |
| Ares Acquisition Corp | *W EXP 02/02/202 | G33032122 | $333.6K | 504,706 | 0.2% |
| Bridgetown Holdings LTD | *W EXP 09/30/202 | G1355U121 | $304.3K | 895,000 | 0.2% |
| Churchill Capital Corp VII | *W EXP 02/29/202 | 17144M110 | $168.8K | 548,000 | 0.1% |
| Calidi Biotherapeutics Inc | *W EXP 03/14/202 | 320703119 | $144.1K | 655,200 | 0.1% |
| Compass Digital Acquisition Corp(COMP) | *W EXP 09/29/202 | G2476C123 | $101.3K | 459,906 | 0.1% |
| Churchill Capital Corp VI | *W EXP 02/17/202 | 17143W119 | $86.4K | 540,000 | 0.0% |
| Ross Acquisition Corp II | *W EXP 02/01/202 | G7641C114 | $49.0K | 439,666 | 0.0% |
| Concord Acquisition Corp II | *W EXP 99/99/999 | 20607U116 | $42.6K | 408,333 | 0.0% |
| Swiftmerge Acquisition Corp | *W EXP 12/13/202 | G63836111 | $34.6K | 490,000 | 0.0% |
| YS Biopharma Co LTD | *W EXP 03/15/202 | G9845F117 | $17.2K | 489,999 | 0.0% |
| Marblegate Acquisition Corp | *W EXP 08/31/202 | 56608A113 | $13.5K | 735,000 | 0.0% |
| Home Plate Acquisition Corp | *W EXP 09/30/202 | 43734R111 | $0 | 690,000 | 0.0% |
| Churchill Capital Corp V | *W EXP 10/29/202 | 17144T115 | $0 | 612,000 | 0.0% |